300452 山河药辅
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)14.19413.48620.33719.18614.569
总资产报酬率 ROA (%)8.3237.69911.86312.1989.579
投入资产回报率 ROIC (%)9.5829.04514.57515.53912.192

边际利润分析
销售毛利率 (%)31.87531.04031.69129.77528.892
营业利润率 (%)21.57316.23322.09619.34316.168
息税前利润/营业总收入 (%)22.86617.30022.50019.04015.843
净利润/营业总收入 (%)19.02913.65619.61518.58513.870

收益指标分析
经营活动净收益/利润总额(%)83.930104.90382.96587.20195.116
价值变动净收益/利润总额(%)8.72711.30610.2533.7458.094
营业外收支净额/利润总额(%)0.071-0.6410.2020.092-3.131

偿债能力分析
流动比率 (X)4.5814.3753.4361.8292.476
速动比率 (X)4.2293.9953.0921.5642.128
资产负债率 (%)36.44637.47039.37633.19926.664
带息债务/全部投入资本 (%)28.55428.79029.58516.44811.598
股东权益/带息债务 (%)237.083233.790225.877477.156724.440
股东权益/负债合计 (%)162.500154.853142.576184.348249.352
利息保障倍数 (X)17.90114.78562.698-59.22695.538

营运能力分析
应收账款周转天数 (天)50.72538.37528.71728.02629.581
存货周转天数 (天)48.54954.08158.18061.47351.976